Monopar Therapeutics Inc. Banner Image

Monopar Therapeutics Inc. has reached its limit for free report views

Work for Monopar Therapeutics Inc.? Upgrade Your Profile and unlock all your annual reports.

Monopar Therapeutics Inc.

  • Ticker MNPR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Monopar Therapeutics Inc. Logo Image
  • 1-10 Employees
  • Based in Wilmette, Illinois
Monopar Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar's pipeline consists of ValidiveĀ® for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the treatment of advanced softMore tissue sarcoma; and a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19.
Monopar Therapeutics Inc.

Most Recent Annual Report

Monopar Therapeutics Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Monopar Therapeutics Inc. has reached its limit for free report views.

Older/Archived Annual Reports